{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:20:00Z","timestamp":1792466400284,"version":"4.5.0"},"reference-count":34,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,2,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Diffuse large B-cell lymphoma is the most frequent type of B-cell lymphoma in adult patients but also occurs in children. Patients are currently assigned to therapy regimens based on arbitrarily chosen age limits only (eg, 18 or 60 years) and not biologically justified limits. A total of 364 diffuse large B-cell lymphomas and related mature aggressive B-cell lymphomas other than Burkitt lymphoma from all age groups were analyzed by comprehensive molecular profiling. The probability of several biologic features previously reported to be associated with poor prognosis in diffuse large B-cell lymphoma, such as ABC subtype, BCL2 expression, or cytogenetic complexity, increases with age at diagnosis. Similarly, various genetic features, such as IRF4 translocations, gains in 1q21, 18q21, 7p22, and 7q21, as well as changes in 3q27, including gains and translocations affecting the BCL6 locus, are significantly associated with patient age, but no cut-offs between age groups could be defined. If age was incorporated in multivariate analyses, genetic complexity lost its prognostic significance, whereas the prognostic impact of ABC subtype and age were additive. Our data indicate that aging is a major determinant of lymphoma biology. They challenge current concepts regarding both prognostic biomarkers and treatment stratification based on strict age cut-offs.<\/jats:p>","DOI":"10.1182\/blood-2011-10-388470","type":"journal-article","created":{"date-parts":[[2012,1,12]],"date-time":"2012-01-12T00:58:13Z","timestamp":1326329893000},"page":"1882-1887","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":171,"title":["Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma"],"prefix":"10.1182","volume":"119","author":[{"given":"Wolfram","family":"Klapper","sequence":"first","affiliation":[{"name":"Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel\/University of Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Kreuz","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Kohler","sequence":"additional","affiliation":[{"name":"Institute of Functional Genomics, University of Regensburg, Regensburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Burkhardt","sequence":"additional","affiliation":[{"name":"NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Szczepanowski","sequence":"additional","affiliation":[{"name":"Department of Pathology, Hematopathology Section and Lymph Node Registry, University Hospital Schleswig-Holstein, Campus Kiel\/University of Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itziar","family":"Salaverria","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel\/University of Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Campus Benjamin Franklin, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Berlin, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Loeffler","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Pellissery","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel\/University of Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Woessmann","sequence":"additional","affiliation":[{"name":"NHL-BFM Study Center, Department of Pediatric Hematology and Oncology, Justus-Liebig-University, Giessen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Schw\u00e4nen","sequence":"additional","affiliation":[{"name":"Cytogenetic and Molecular Diagnostics, Internal Medicine III, University Hospital of Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Tr\u00fcmper","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Georg-August University of G\u00f6ttingen, G\u00f6ttingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swen","family":"Wessendorf","sequence":"additional","affiliation":[{"name":"Cytogenetic and Molecular Diagnostics, Internal Medicine III, University Hospital of Ulm, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Spang","sequence":"additional","affiliation":[{"name":"Institute of Functional Genomics, University of Regensburg, Regensburg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Hasenclever","sequence":"additional","affiliation":[{"name":"Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Siebert","sequence":"additional","affiliation":[{"name":"Department of Human Genetics, University Hospital Schleswig-Holstein, Campus Kiel\/University of Kiel, Kiel, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111807531594700_B1","volume-title":"WHO Classification of Tumors of the Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008"},{"issue":"1","key":"2019111807531594700_B2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nm0102-68","article-title":"Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.","volume":"8","author":"Shipp","year":"2002","journal-title":"Nat Med"},{"issue":"25","key":"2019111807531594700_B3","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa012914","article-title":"The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.","volume":"346","author":"Rosenwald","year":"2002","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111807531594700_B4","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","article-title":"Stromal gene signatures in large-B-cell lymphomas.","volume":"359","author":"Lenz","year":"2008","journal-title":"N Engl J Med"},{"issue":"23","key":"2019111807531594700_B5","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","article-title":"A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling.","volume":"354","author":"Hummel","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"2019111807531594700_B6","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1200\/JCO.1996.14.7.2131","article-title":"Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study.","volume":"14","author":"Kramer","year":"1996","journal-title":"J Clin Oncol"},{"issue":"12","key":"2019111807531594700_B7","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","article-title":"Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).","volume":"22","author":"Klapper","year":"2008","journal-title":"Leukemia"},{"issue":"17","key":"2019111807531594700_B8","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","article-title":"MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy.","volume":"114","author":"Savage","year":"2009","journal-title":"Blood"},{"issue":"33","key":"2019111807531594700_B9","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1200\/JCO.2009.22.7058","article-title":"Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: a GELA study.","volume":"27","author":"Copie-Bergman","year":"2009","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019111807531594700_B10","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/blood.V77.7.1508.1508","article-title":"Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin's lymphoma: clinical correlations.","volume":"77","author":"Offit","year":"1991","journal-title":"Blood"},{"issue":"14","key":"2019111807531594700_B11","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma.","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111807531594700_B12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2141.2008.06988.x","article-title":"Recent advances in the understanding and management of diffuse large B-cell lymphoma in children.","volume":"142","author":"Reiter","year":"2008","journal-title":"Br J Haematol"},{"issue":"3","key":"2019111807531594700_B13","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1182\/blood-2004-03-0973","article-title":"The impact of the methotrexate administration schedule and dose in the treatment of children and adolescents with B-cell neoplasms: a report of the BFM group study NHL-BFM95.","volume":"105","author":"Woessmann","year":"2004","journal-title":"Blood"},{"issue":"4","key":"2019111807531594700_B14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111807531594700_B15","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1470-2045(06)70664-7","article-title":"CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.","volume":"7","author":"Pfreundschuh","year":"2006","journal-title":"Lancet Oncol"},{"issue":"10","key":"2019111807531594700_B16","first-page":"3294","article-title":"Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90.","volume":"94","author":"Reiter","year":"1999","journal-title":"Blood"},{"issue":"11","key":"2019111807531594700_B17","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1182\/blood.V97.11.3370","article-title":"The Societe Francaise d'Oncologie Pediatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.","volume":"97","author":"Patte","year":"2001","journal-title":"Blood"},{"issue":"10","key":"2019111807531594700_B18","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2005-10-4213","article-title":"Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) Multicenter Trial.","volume":"107","author":"Oschlies","year":"2006","journal-title":"Blood"},{"issue":"4","key":"2019111807531594700_B19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1182\/blood-2008-01-136465","article-title":"Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials.","volume":"112","author":"Klapper","year":"2008","journal-title":"Blood"},{"issue":"1","key":"2019111807531594700_B20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2141.2005.05735.x","article-title":"The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.","volume":"131","author":"Burkhardt","year":"2005","journal-title":"Br J Haematol"},{"issue":"1","key":"2019111807531594700_B21","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults.","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"issue":"2","key":"2019111807531594700_B22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/jcp.2008.057257","article-title":"Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium).","volume":"62","author":"de Jong","year":"2009","journal-title":"J Clin Pathol"},{"issue":"9","key":"2019111807531594700_B23","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/leu.2008.166","article-title":"Pathway activation patterns in diffuse large B-cell lymphomas.","volume":"22","author":"Bentink","year":"2008","journal-title":"Leukemia"},{"issue":"4","key":"2019111807531594700_B24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/gcc.10155","article-title":"DNA microarrays for comparative genomic hybridization based on DOP-PCR amplification of BAC and PAC clones.","volume":"36","author":"Fiegler","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"2019111807531594700_B25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1073\/pnas.0304717101","article-title":"Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations.","volume":"101","author":"Schwaenen","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019111807531594700_B26","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1160\/ME9064","article-title":"Development and implementation of an analysis tool for array-based comparative genomic hybridization.","volume":"46","author":"Kreuz","year":"2007","journal-title":"Methods Inf Med"},{"issue":"2","key":"2019111807531594700_B27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","article-title":"FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue.","volume":"8","author":"Ventura","year":"2006","journal-title":"J Mol Diagn"},{"issue":"2","key":"2019111807531594700_B28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin.","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"3","key":"2019111807531594700_B29","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pbc.21619","article-title":"Pediatric diffuse large B-cell lymphoma demonstrates a high proliferation index, frequent c-Myc protein expression, and a high incidence of germinal center subtype: report of the French-American-British (FAB) international study group.","volume":"51","author":"Miles","year":"2008","journal-title":"Pediatr Blood Cancer"},{"issue":"36","key":"2019111807531594700_B30","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2019111807531594700_B31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S1470-2045(09)70369-9","article-title":"Genetic aberrations in paediatric acute leukaemias and implications for management of patients.","volume":"11","author":"Szczepanski","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"2019111807531594700_B32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3324\/haematol.2009.013177","article-title":"Pediatric follicular lymphoma: a clinico-pathological study of a population-based series of patients treated within the NHL-BFM (Berlin-Frankfurt-Munster) multicenter trials.","volume":"95","author":"Oschlies","year":"2010","journal-title":"Haematologica"},{"issue":"14","key":"2019111807531594700_B33","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1200\/JCO.2009.26.2493","article-title":"Standard International Prognostic Index remains a valid predictor of outcome for patients with aggressive CD20+ B-cell lymphoma in the rituximab era.","volume":"28","author":"Ziepert","year":"2010","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019111807531594700_B34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1365-2141.2009.07762.x","article-title":"BCL2 expression in de novo diffuse large B-cell lymphoma partly reflects normal differences in age distribution.","volume":"146","author":"Thunberg","year":"2009","journal-title":"Br J Haematol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/8\/1882\/1354772\/zh800812001882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/8\/1882\/1354772\/zh800812001882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T08:07:16Z","timestamp":1574064436000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/8\/1882\/30378\/Patient-age-at-diagnosis-is-associated-with-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,23]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,2,23]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2011-10-388470","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,23]]}}}